| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | VP of Finance & Corp. Contr. | Common Stock | 5,284 | $3,381 | $0.6400 | 13 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | 13 Feb 2026 | 0 | $0 | 3 | VP of Finance & Corp. Contr. | 13 Mar 2026, 16:11 |